Table S2.
Chemotherapy compounds | Mode of action | Patient plasma concentration, mM | Ref. |
5-FU | Blocks thymidylic acid formation; DNA biosynthesis | 426.2 | 46 |
Oxaliplatin | DNA crossliking agent; preventing DNA replication and transcription | 8.1 | 47 |
Folinic acid or leucoverin | Stabilizes binding of 5-FU to thymidylate synthase | 18.5 | 48 |
Irinotecan | Analog of camptothecin, inhibits topoisomerase activity, blocking DNA replication, and transcription | 8 | 49 |